Quantum Biopharma (QNTM) Short term Debt (2024 - 2026)

Quantum Biopharma (QNTM) has 3 years of Short term Debt data on file, last reported at $485517.0 in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt rose 209.4% year-over-year to $485517.0; the trailing twelve-month figure through Mar 2026 stood at $485517.0 (up 209.4% YoY), and the FY2025 full-year result was $472497.0, up 210.62% from the prior year.
• Short term Debt advanced to $485517.0 in Q1 2026, from $472497.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $485517.0 in Q1 2026 to a low of $152113.0 in Q4 2024.
• A 3-year average of $310186.2 and a median of $297035.0 in 2025 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt jumped 210.62% in 2025 and surged 209.4% in 2026, its largest moves.
• Tracing QNTM's Short term Debt over 3 years: stood at $152113.0 in 2024, then jumped by 210.62% to $472497.0 in 2025, then advanced by 2.76% to $485517.0 in 2026.
• Business Quant data shows QNTM's Short term Debt at $485517.0 in Q1 2026, $472497.0 in Q4 2025, and $429995.0 in Q3 2025.